Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
Correspondence to Professor Christian Kopkow, Department für Angewandte Gesundheitswissenschaften, Hochschule für Gesundheit (University of Applied Sciences), Gesundheitscampus 6–8, Bochum 44801, ...
1 NSW Centre for the Advancement of Adolescent Health, Department of Paediatrics and Child Health, University of Sydney at The Children's Hospital at Westmead, New South Wales, Australia 2 Physical ...